Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

TWD 27.9

(-0.18%)

Total Debt Summary of Chi Sheng Pharma & Biotech Co., Ltd

  • Chi Sheng Pharma & Biotech Co., Ltd's latest annual total debt in 2023 was 120 Million TWD , down -57.68% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd's latest quarterly total debt in 2024 Q2 was 260.08 Million TWD , down -10.16% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported annual total debt of 290.37 Million TWD in 2022, down -0.62% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported annual total debt of 292.19 Million TWD in 2021, up 96.68% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported quarterly total debt of 260.08 Million TWD for 2024 Q2, down -10.16% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported quarterly total debt of 282.24 Million TWD for 2023 Q3, up 27.86% from previous quarter.

Annual Total Debt Chart of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Historical Annual Total Debt of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Year Total Debt Total Debt Growth
2023 120 Million TWD -57.68%
2022 290.37 Million TWD -0.62%
2021 292.19 Million TWD 96.68%
2020 148.56 Million TWD -14.0%
2019 172.75 Million TWD 0.0%

Peer Total Debt Comparison of Chi Sheng Pharma & Biotech Co., Ltd

Name Total Debt Total Debt Difference
St.Shine Optical Co.,Ltd. 662.27 Million TWD 81.881%
Bioteque Corporation 894.74 Million TWD 86.588%
Sunder Biomedical Tech. Co., Ltd. 491.28 Million TWD 75.574%
BenQ Medical Technology Corporation 1.23 Billion TWD 90.293%
Pacific Hospital Supply Co., Ltd 437.43 Million TWD 72.567%
Unicon Optical Co., Ltd. 281.6 Million TWD 57.387%
Formosa Optical Technology Co.,Ltd. 2.91 Billion TWD 95.888%
Medeon Biodesign, Inc. 47.14 Million TWD -154.534%
Concord Medical Co., Ltd. 216.04 Million TWD 44.455%
Crystalvue Medical Corporation 25.03 Million TWD -379.425%
Perfect Medical Industry Co., Ltd. 211.96 Million TWD 43.386%
ICARES Medicus, Inc. 121.63 Million TWD 1.345%
Lagis Enterprise Co., Ltd. 177.66 Million TWD 32.455%
Amed Co., Ltd. 257.39 Million TWD 53.378%